Galectin-3 Monoclonal Antibody(2F9)

This gene encodes a member of the galectin family of carbohydrate binding proteins. Members of this protein family have an affinity for beta-galactosides. The encoded protein is characterized by an N-terminal proline-rich tandem repeat domain and a single C-terminal carbohydrate recognition domain. This protein can self-associate through the N-terminal domain allowing it to bind to multivalent saccharide ligands. This protein localizes to the extracellular matrix, the cytoplasm and the nucleus. This protein plays a role in numerous cellular functions including apoptosis, innate immunity, cell adhesion and T-cell regulation. The protein exhibits antimicrobial activity against bacteria and fungi. Alternate splicing results in multiple transcript variants.

Introducing the GALECTIN-3 Monoclonal Antibody (2F9), a cutting-edge product designed to revolutionize the field of biomedical research. This highly advanced antibody is meticulously engineered to specifically target and bind to the galectin-3 protein, offering unprecedented accuracy and precision in scientific investigations.

The GALECTIN-3 Monoclonal Antibody (2F9) boasts exceptional specificity, ensuring minimal cross-reactivity with other proteins, thus guaranteeing reliable and reproducible results. Its superior affinity for galectin-3 enables researchers to delve deeper into the intricate mechanisms and functions of this protein, unraveling its role in various physiological and pathological processes.

Crafted with utmost care and utilizing state-of-the-art technology, this monoclonal antibody exhibits exceptional stability and consistency, ensuring consistent performance across multiple experiments. Its high purity and low endotoxin levels further enhance its suitability for a wide range of applications, including immunohistochemistry, western blotting, and flow cytometry.

The GALECTIN-3 Monoclonal Antibody (2F9) is meticulously validated through rigorous quality control measures, guaranteeing its reliability and reproducibility. Its exceptional performance has been demonstrated in numerous scientific studies, making it an indispensable tool for researchers seeking to unravel the complexities of galectin-3 biology.

In summary, the GALECTIN-3 Monoclonal Antibody (2F9) represents a breakthrough in biomedical research, offering unparalleled specificity, stability, and reliability. With its exceptional performance and versatility, this antibody is poised to revolutionize the understanding of galectin-3 and pave the way for groundbreaking discoveries in the field.